Patricia Laplante
InvestorPrincipal at AmorChem
About
Patricia Laplante is a Principal at AmorChem, where she develops and manages technical maturation plans for the firm's drug discovery projects and supports academic research teams moving into drug discovery. She joined AmorChem in 2013 as a Project Manager and later became Director, Project Management, having previously spent 11 years in drug discovery at AstraZeneca R&D Montreal along with roles at Procyon BioPharma and McGill University. She holds an MSc in neurology and neurosurgery from McGill University.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
SemaThera
Per the firm's website.
Colleagues at AmorChem
Frequently asked questions
- Who is Patricia Laplante?
- Patricia Laplante is a Principal at AmorChem, where she develops and manages technical maturation plans for the firm's drug discovery projects and supports academic research teams moving into drug discovery. She joined AmorChem in 2013 as a Project Manager and later became Director, Project Management, having previously spent 11 years in drug discovery at AstraZeneca R&D Montreal along with roles at Procyon BioPharma and McGill University. She holds an MSc in neurology and neurosurgery from McGill University.
- Where does Patricia Laplante work?
- Patricia Laplante is Principal at AmorChem.
- What does Patricia Laplante invest in?
- Patricia Laplante invests in Biotech.
- What companies has Patricia Laplante invested in?
- Investments tracked here include SemaThera.